Balance Sheet
Accounts PayablesAccumulated ExpensesCash & Current InvestmentsCash & EquivalentsCurrent AssetsCurrent TaxesGoodwill & IntangiblesInventoryLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsPayablesProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zhengye Biotechnology Holding (ZYBT) Retained Earnings: 2023-2025

  • Zhengye Biotechnology Holding's Retained Earnings was N/A to $3.7 million in Q2 2025 from the same period last year, while for Jun 2025 it was $3.7 million, marking a year-over-year change of. This contributed to the annual value of $6.7 million for FY2024, which is 23.39% up from last year.
  • As of Q2 2025, Zhengye Biotechnology Holding's Retained Earnings stood at $3.7 million, which was down 44.50% from $6.6 million recorded in Q4 2024.
  • Over the past 5 years, Zhengye Biotechnology Holding's Retained Earnings peaked at $6.6 million during Q4 2024, and registered a low of $3.7 million during Q2 2025.
  • Moreover, its 3-year median value for Retained Earnings was $5.3 million (2023), whereas its average is $5.2 million.
  • Data for Zhengye Biotechnology Holding's Retained Earnings shows a peak YoY climbed of 23.76% (in 2024) over the last 5 years.
  • Over the past 3 years, Zhengye Biotechnology Holding's Retained Earnings (Quarterly) stood at $5.3 million in 2023, then increased by 23.76% to $6.6 million in 2024, then reached $3.7 million in 2025.
  • Its last three reported values are $3.7 million in Q2 2025, $6.6 million for Q4 2024, and $5.3 million during Q4 2023.